SI1067941T1 - Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivate - Google Patents
Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivateInfo
- Publication number
- SI1067941T1 SI1067941T1 SI9930675T SI9930675T SI1067941T1 SI 1067941 T1 SI1067941 T1 SI 1067941T1 SI 9930675 T SI9930675 T SI 9930675T SI 9930675 T SI9930675 T SI 9930675T SI 1067941 T1 SI1067941 T1 SI 1067941T1
- Authority
- SI
- Slovenia
- Prior art keywords
- composition containing
- synergistic combination
- anthracycline derivative
- antitumor composition
- camptothecin derivate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9806324.1A GB9806324D0 (en) | 1998-03-24 | 1998-03-24 | Antitumour synergetic composition |
| PCT/EP1999/001897 WO1999048503A1 (en) | 1998-03-24 | 1999-03-19 | Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivate |
| EP99914528A EP1067941B1 (en) | 1998-03-24 | 1999-03-19 | Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1067941T1 true SI1067941T1 (en) | 2005-02-28 |
Family
ID=10829188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI9930675T SI1067941T1 (en) | 1998-03-24 | 1999-03-19 | Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivate |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US6403563B1 (uk) |
| EP (1) | EP1067941B1 (uk) |
| JP (1) | JP2002507571A (uk) |
| KR (1) | KR20010034619A (uk) |
| CN (2) | CN1150002C (uk) |
| AR (1) | AR018166A1 (uk) |
| AT (1) | ATE271388T1 (uk) |
| AU (1) | AU758191B2 (uk) |
| BR (1) | BR9908391A (uk) |
| CA (1) | CA2324610A1 (uk) |
| CZ (1) | CZ295368B6 (uk) |
| DE (1) | DE69918819T2 (uk) |
| DK (1) | DK1067941T3 (uk) |
| EA (1) | EA003134B1 (uk) |
| ES (1) | ES2226366T3 (uk) |
| GB (1) | GB9806324D0 (uk) |
| HU (1) | HUP0101615A3 (uk) |
| ID (1) | ID26091A (uk) |
| IL (1) | IL138035A0 (uk) |
| MY (1) | MY133016A (uk) |
| NO (1) | NO20004703L (uk) |
| NZ (1) | NZ507570A (uk) |
| PL (1) | PL343098A1 (uk) |
| PT (1) | PT1067941E (uk) |
| SI (1) | SI1067941T1 (uk) |
| TW (1) | TW576740B (uk) |
| UA (1) | UA63000C2 (uk) |
| WO (1) | WO1999048503A1 (uk) |
| ZA (1) | ZA992255B (uk) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6820065B1 (en) * | 1998-03-18 | 2004-11-16 | Ascom Hasler Mailing Systems Inc. | System and method for management of postage meter licenses |
| GB9904387D0 (en) * | 1999-02-25 | 1999-04-21 | Pharmacia & Upjohn Spa | Antitumour synergistic composition |
| GB9909925D0 (en) * | 1999-04-29 | 1999-06-30 | Pharmacia & Upjohn Spa | Combined preparations comprising anthracycline derivatives |
| GB9916882D0 (en) * | 1999-07-19 | 1999-09-22 | Pharmacia & Upjohn Spa | Antitumor synergistic composition |
| GB9926843D0 (en) * | 1999-11-12 | 2000-01-12 | Pharmacia & Upjohn Spa | Lipid complex of alkycyclines |
| US6627614B1 (en) * | 2002-06-05 | 2003-09-30 | Super Gen, Inc. | Sequential therapy comprising a 20(S)-camptothecin and an anthracycline |
| EP1985286A1 (en) * | 2007-04-24 | 2008-10-29 | Biocompatibles UK Limited | Microspheres for treatment of brain tumours |
| US8349764B2 (en) | 2007-10-31 | 2013-01-08 | Molycorp Minerals, Llc | Composition for treating a fluid |
| US20090107925A1 (en) * | 2007-10-31 | 2009-04-30 | Chevron U.S.A. Inc. | Apparatus and process for treating an aqueous solution containing biological contaminants |
| US20110207760A1 (en) * | 2010-02-23 | 2011-08-25 | Valery Alakhov | Sn-38 compositions |
| WO2011160063A2 (en) | 2010-06-18 | 2011-12-22 | Myriad Genetics, Inc. | Methods and materials for assessing loss of heterozygosity |
| DK2609216T3 (en) | 2010-08-24 | 2016-09-12 | Dana Farber Cancer Inst Inc | Methods to predict anti-cancer response |
| US9233863B2 (en) | 2011-04-13 | 2016-01-12 | Molycorp Minerals, Llc | Rare earth removal of hydrated and hydroxyl species |
| EP2721181B1 (en) | 2011-06-17 | 2019-12-18 | Myriad Genetics, Inc. | Methods and materials for assessing allelic imbalance |
| AU2012358244A1 (en) | 2011-12-21 | 2014-06-12 | Myriad Genetics, Inc. | Methods and materials for assessing loss of heterozygosity |
| NZ628813A (en) | 2012-02-23 | 2015-10-30 | Univ Denmark Tech Dtu | Methods for predicting anti-cancer response |
| CA3190075A1 (en) | 2012-06-07 | 2013-12-12 | Institut Curie | Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors |
| US10308986B2 (en) | 2013-03-14 | 2019-06-04 | Children's Medical Center Corporation | Cancer diagnosis, treatment selection and treatment |
| AU2014248007B2 (en) | 2013-04-05 | 2020-03-26 | Myriad Genetics, Inc. | Methods and materials for assessing homologous recombination deficiency |
| US11149316B2 (en) | 2013-12-09 | 2021-10-19 | Institut Curie | Methods for detecting inactivation of the homologous recombination pathway (BRCA1/2) in human tumors |
| MX370462B (es) | 2014-03-07 | 2019-12-13 | Secure Natural Resources Llc | Oxido de cerio (iv) con propiedades de remocion de arsenico excepcionales. |
| DK3180447T3 (da) | 2014-08-15 | 2020-06-15 | Myriad Genetics Inc | Fremgangsmåder og materialer til analyse af homolog rekombinationsdeficiens |
| EP4141127A1 (en) | 2021-08-30 | 2023-03-01 | Zentrum Familiärer Brust- und Eierstockkrebs Universitätsklinik Köln | Method for assessing homologous recombination deficiency in ovarian cancer cells |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9114549D0 (en) * | 1991-07-05 | 1991-08-21 | Erba Carlo Spa | Mono and bis alkylamino-anthracyclines |
| GB9325417D0 (en) * | 1993-12-13 | 1994-02-16 | Erba Carlo Spa | 3'- aziridino-anthracycline derivatives |
-
1998
- 1998-03-24 GB GBGB9806324.1A patent/GB9806324D0/en not_active Ceased
-
1999
- 1999-02-25 TW TW088102834A patent/TW576740B/zh not_active IP Right Cessation
- 1999-03-19 ID IDW20001882A patent/ID26091A/id unknown
- 1999-03-19 PL PL99343098A patent/PL343098A1/xx unknown
- 1999-03-19 SI SI9930675T patent/SI1067941T1/xx unknown
- 1999-03-19 CN CNB998043141A patent/CN1150002C/zh not_active Expired - Fee Related
- 1999-03-19 CA CA002324610A patent/CA2324610A1/en not_active Abandoned
- 1999-03-19 CN CNA2004100317041A patent/CN1528334A/zh active Pending
- 1999-03-19 NZ NZ507570A patent/NZ507570A/xx unknown
- 1999-03-19 PT PT99914528T patent/PT1067941E/pt unknown
- 1999-03-19 KR KR1020007010503A patent/KR20010034619A/ko not_active Application Discontinuation
- 1999-03-19 DK DK99914528T patent/DK1067941T3/da active
- 1999-03-19 CZ CZ20003493A patent/CZ295368B6/cs not_active IP Right Cessation
- 1999-03-19 EP EP99914528A patent/EP1067941B1/en not_active Expired - Lifetime
- 1999-03-19 ES ES99914528T patent/ES2226366T3/es not_active Expired - Lifetime
- 1999-03-19 AU AU33314/99A patent/AU758191B2/en not_active Ceased
- 1999-03-19 HU HU0101615A patent/HUP0101615A3/hu unknown
- 1999-03-19 DE DE69918819T patent/DE69918819T2/de not_active Expired - Fee Related
- 1999-03-19 AT AT99914528T patent/ATE271388T1/de not_active IP Right Cessation
- 1999-03-19 US US09/646,096 patent/US6403563B1/en not_active Expired - Fee Related
- 1999-03-19 WO PCT/EP1999/001897 patent/WO1999048503A1/en not_active Application Discontinuation
- 1999-03-19 IL IL13803599A patent/IL138035A0/xx unknown
- 1999-03-19 JP JP2000537551A patent/JP2002507571A/ja not_active Withdrawn
- 1999-03-19 UA UA2000105982A patent/UA63000C2/uk unknown
- 1999-03-19 BR BR9908391-4A patent/BR9908391A/pt not_active IP Right Cessation
- 1999-03-19 EA EA200000978A patent/EA003134B1/ru not_active IP Right Cessation
- 1999-03-22 AR ARP990101246A patent/AR018166A1/es unknown
- 1999-03-22 MY MYPI99001071A patent/MY133016A/en unknown
- 1999-03-23 ZA ZA9902255A patent/ZA992255B/xx unknown
-
2000
- 2000-09-20 NO NO20004703A patent/NO20004703L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0101615A3 (en) | Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivate | |
| HK1044466A1 (zh) | 抗腫瘤的協同組合物 | |
| SG75160A1 (en) | Compounds with protected hydroxy groups | |
| HK1031222A1 (en) | Camptothecin derivatives having antitumor activity | |
| HUP0104255A3 (en) | An pharmaceutical composition suitable for inhalation | |
| HK1156853A1 (en) | Topical composition comprising n-acetyl glucosamine n- | |
| HUP0103256A3 (en) | Thiobenzimidazole derivatives and pharmaceutical compositions containing the compounds | |
| PL349427A1 (en) | Fibre blend for enteral composition | |
| HK1068210A1 (en) | Illudin analogs usefull as antitumor agents | |
| PL343627A1 (en) | Medicinal compositions | |
| AU1929100A (en) | Adhesive compositions with retarding additive | |
| HK1041482B (zh) | 作為細胞毒性抗腫瘤劑的萘並噻吩和二氫苯並噻吩的衍生物 | |
| HUP0103924A2 (hu) | Buprenorfin tartalmú orális gyógyszerkészítmények | |
| AU7377200A (en) | Combination therapy including camptothecin | |
| NZ512210A (en) | Camptothecin analogs useful for treating cancer and leukemia | |
| AU4168899A (en) | Benzanilide derivatives and medicinal compositions | |
| GB2296495B (en) | Anthracycline derivatives | |
| EP1109552A4 (en) | NOVEL ANTICANCING AGENTS GENERATING DNA CLEAVAGE | |
| IL134592A0 (en) | Compositions comprising camptothecin compounds for the treatment of cancer with reduced side effects | |
| ZA982863B (en) | Synergistic fungicadal composition | |
| AU3410099A (en) | Pharmaceutical compositions containing melatonin inclusion complexes | |
| GB9802041D0 (en) | Complexing compositions | |
| AP9901525A0 (en) | 2"-Deoxy hydromycin derivatives | |
| EP1124552A4 (en) | CHRYSE DERIVATIVES AS ANTITUMULAR AGENTS | |
| GB0125901D0 (en) | Compositions stabilized dioxopiperazinyl derivatives |